$0.6730
-0.0377-5.3%
마지막 업데이트: Oct 14, 4:02 PM
$0.6500
-0.0607-8.54%
Benzinga
Benzinga
Benzinga
수요일, 10월 14
Benzinga
© 2026 Benzinga | All Rights Reserved
Lantern Pharma (LTRN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.38 | $-0.36 | $-0.45 | $-0.46 |
| Actual | $-0.57 | $-0.30 | $-0.36 | $-0.39 |
| Surprise | -50.0% | +16.7% | +20.0% | +15.2% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.38 | $-0.44 |
| Revenue | ||
| Consensus | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-0.57 | $-0.38 | -50.0 % |
| Q1 | May 15, 2026 | $-0.30 | $-0.36 | 16.7 % |
| Q4 | Mar 30, 2026 | $-0.36 | $-0.45 | 20.0 % |
| Q3 | Nov 12, 2025 | $-0.39 | $-0.46 | 15.2 % |